By my reckoning they have five valuable assets that are all ready to monetise:-
Vivagel
Viraleze
DEP Cabazitaxel
DEP Docetaxel
DEP Irinotecan
If management cannot get some sort of deal from one of the above then they do not deserve to continue with a capital raise bailout. The last one was for $1.50, remember, and where has all that money gone?
I will not support a CR until some deals have been struck and the SP has recovered.
SPL Price at posting:
11.3¢ Sentiment: Hold Disclosure: Held
